AtriCure's Coolrail(TM) Linear Ablation Pen Receives FDA 510(k) Clearance (PR Newswire via Yahoo! Finance)
AtriCure, Inc. , a medical device company and leader in cardiac surgical ablation systems, today announced that its Coolrail linear ablation pen received 510 clearance from the FDA for the ablation of cardiac tissue.

Watson Files For FDA Approval Of Generic Form Of Period-Free Contraceptive (Medical News Today)
Watson Pharmaceuticals said Thursday that it has filed an FDA application to market its generic form of the period-free oral contraceptive Lybrel, Reuters reports. However, the pharmaceutical company Wyeth, which produces Lybrel, filed a federal lawsuit seeking to block the application, according to Watson (Reuters, 3/13). Watson is seeking to sell a generic version of Lybrel in the U.S.